Nuvectis Pharma Ownership | Who Owns Nuvectis Pharma?
Nuvectis Pharma Ownership Summary
Nuvectis Pharma is owned by 7.54% institutional investors, 44.38% insiders, and 48.08% retail investors. Baldwin brothers llc/ma is the largest institutional shareholder, holding 2.07% of NVCT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.99% of its assets in Nuvectis Pharma shares.
NVCT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Nuvectis Pharma | 7.54% | 44.38% | 48.08% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Baldwin brothers llc/ma | 355.96K | 2.07% | $1.93M |
Vanguard group | 325.30K | 1.89% | $1.76M |
Marshall wace, llp | 124.57K | 0.72% | $673.93K |
Blackrock | 83.41K | 0.50% | $528.00K |
Geode capital management | 79.24K | 0.46% | $428.78K |
Goldman sachs group | 61.57K | 0.37% | $389.74K |
Blackrock funding, inc. /de | 62.34K | 0.36% | $337.27K |
Forbes j m & co llp | 59.00K | 0.34% | $319.19K |
Northern trust | 49.83K | 0.30% | $315.40K |
Susquehanna group, llp | 45.61K | 0.26% | $246.73K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Baldwin brothers llc/ma | 355.96K | 0.13% | $1.93M |
Forbes j m & co llp | 59.00K | 0.03% | $319.19K |
Gsa capital partners llp | 34.75K | 0.01% | $188.00K |
Baxter bros | 15.00K | 0.01% | $81.15K |
Point72 asia (singapore) pte. | 4.48K | 0.01% | $24.23K |
Nations financial group inc, /ia/ /adv | 13.50K | 0.01% | $73.03K |
Oppenheimer | 25.00K | 0.00% | $135.25K |
Edmond de rothschild | 15.17K | 0.00% | $82.07K |
Marshall wace, llp | 124.57K | 0.00% | $673.93K |
Qube research | 30.59K | 0.00% | $165.51K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Baldwin brothers llc/ma | 355.96K | 0.13% | 181.83K |
Marshall wace, llp | 124.57K | 0.00% | 81.76K |
Goldman sachs group | 61.57K | 0.00% | 61.57K |
Oppenheimer | 25.00K | 0.00% | 25.00K |
Vanguard group | 325.30K | - | 24.16K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 83.41K | - | -289.31K |
State street | 15.30K | - | -114.08K |
Iridian asset management llc/ct | - | - | -55.38K |
Millennium management | 29.70K | 0.00% | -38.80K |
Morgan stanley | 10.20K | - | -30.99K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Goldman sachs group | 61.57K | 0.00% | 61.57K | $389.74K |
Oppenheimer | 25.00K | 0.00% | 25.00K | $135.25K |
Squarepoint ops | 19.07K | 0.00% | 19.07K | $103.17K |
Citadel advisors | 14.94K | - | 14.94K | $94.55K |
Cubist systematic strategies | 6.29K | 0.00% | 6.29K | $34.05K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -1.00 |
Nbc securities | -5.00 |
Nisa investment advisors | -12.00 |
Gamma investing | -25.00 |
Amalgamated bank | -231.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 30 | -3.23% | 1,298,778 | 23.77% | 7 | 20.32% | 20 | 53.85% | 8 | -27.27% |
Sep 30, 2024 | 31 | -18.42% | 1,049,389 | -12.85% | 6 | 11.52% | 14 | -44.00% | 11 | - |
Jun 30, 2024 | 38 | -5.00% | 1,204,111 | -22.91% | 7 | 9.04% | 25 | 13.64% | 11 | - |
Mar 31, 2024 | 40 | 11.11% | 1,561,981 | 3.22% | 8 | 10.16% | 22 | 4.76% | 11 | 83.33% |
Dec 31, 2023 | 36 | 9.09% | 1,513,319 | 18.48% | 9 | 13.27% | 21 | 40.00% | 6 | -53.85% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 231.04K | 0.99% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 85.43K | 0.37% | 3.67K |
Fidelity Extended Market Index | 36.12K | 0.15% | -230.00 |
Extended Equity Market Fund K | 25.85K | 0.11% | 15.36K |
NT R2000 Growth Index Fund - NL | 20.57K | 0.11% | - |
iShares Micro-Cap ETF | 21.07K | 0.09% | - |
NT R2000 Index Fund - NL | 13.99K | 0.07% | -5.76K |
The Vanguard Russell 2000 Growth Index | 12.03K | 0.06% | - |
NT R2000 Growth Index Fund - L | 11.40K | 0.06% | -3.64K |
Northern Trust Russell 2000 Growth Index | 11.40K | 0.06% | -3.64K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 07, 2025 | Mosseri Marlio Charles | - | Buy | $1.20M |
Dec 24, 2024 | BENTSUR RON | Chairman & CEO | Buy | $20.93K |
Dec 12, 2024 | Mosseri Marlio Charles | - | Buy | $149.04K |
Dec 13, 2024 | Mosseri Marlio Charles | - | Buy | $79.90K |
Dec 13, 2024 | Mosseri Marlio Charles | - | Buy | $79.90K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | 6 | 1 |
2024 Q3 | - | - |
2024 Q2 | 4 | - |
2024 Q1 | 1 | - |
NVCT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools